Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Troubling Trends in Physician Vaccine Confidence in the United States Medical Countermeasures April 5, 2022 …
Northwestern University Researchers Develop Nanoparticle Vaccine Platform Medical Countermeasures March 22, 2022 …
CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats CBRNE March 21, 2022 …
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines Medical Countermeasures March 19, 2022 …
Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus Medical Countermeasures March 10, 2022 …
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate Industry News March 3, 2022 …
Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis CBRNE February 27, 2022 …
Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis Antimicrobial Resistance February 17, 2022 …
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense Industry News February 15, 2022 …
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron Medical Countermeasures February 10, 2022 …
Zika Virus Vaccine Shows Promising Results in Preclinical Studies Medical Countermeasures February 6, 2022 …
First Lethal Hamster Model for SARS-CoV-2 Developed by USAMRIID Scientists Medical Countermeasures February 4, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
Three Doses of mRNA COVID-19 Vaccines Effective Against Hospitalizations for Omicron and Delta Medical Countermeasures January 21, 2022 …
